Aura Biosciences, Inc.
AURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$86,919 | -$76,408 | -$58,763 | -$35,251 |
| Dep. & Amort. | $1,223 | $1,295 | $1,177 | $831 |
| Deferred Tax | $0 | $0 | $0 | $14 |
| Stock-Based Comp. | $11,722 | $8,772 | $6,412 | $2,307 |
| Change in WC | -$2,642 | $4,441 | -$3,102 | -$315 |
| Other Non-Cash | -$3,189 | -$1,947 | -$325 | $4 |
| Operating Cash Flow | -$79,805 | -$63,847 | -$54,601 | -$32,410 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,253 | -$709 | -$1,094 | -$2,125 |
| Net Acquisitions | $0 | $0 | $67 | $0 |
| Inv. Purchases | -$59,108 | -$233,651 | -$119,784 | $0 |
| Inv. Sales/Matur. | $129,182 | $120,397 | $53,009 | $0 |
| Other Inv. Act. | $0 | $0 | -$67 | $0 |
| Investing Cash Flow | $68,821 | -$113,963 | -$67,869 | -$2,125 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,595 | $3,170 | $8,549 | $78,697 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $94,120 | $87,080 | $87,562 |
| Financing Cash Flow | $1,595 | $97,290 | $95,629 | $166,259 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$9,389 | -$80,520 | -$26,841 | $131,724 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,850 | $122,370 | $149,211 | $17,487 |
| End Cash | $32,461 | $41,850 | $122,370 | $149,211 |
| Free Cash Flow | -$81,058 | -$64,556 | -$55,695 | -$34,535 |